Physician profile
Robert J Robbins
NPI 1780792945
$530.18
in general payments reported to CMS, 2019-2025
11 companies · $66.20 in 2025
The $66.20 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $35.45 · 2021: $86.12 · 2022: $99.14 · 2024: $58.13 · 2025: $66.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $124.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $164.08 | 2021-2025 | Avalus, Penditure |
| Boston Scientific Corporation | $113.24 | 2019 | |
| Atricure, INC. | $97.54 | 2019-2022 | |
| Abbvie INC. | $26.70 | 2025 | |
| Abiomed | $24.88 | 2019 | |
| Davol INC. | $21.31 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.99 | 2025 | |
| Medtronic Vascular, INC. | $17.81 | 2020 | |
| Abbott Laboratories | $17.64 | 2020 | |
| Mallinckrodt Enterprises LLC | $16.11 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Robbins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.